DEVELOPMENT AND VALIDATION OF A NOVEL IMMUNOTHERAPY FOR TRAUMATIC HEMORRHAGE

$3,164,353FY2020Defense Health AgencyDOD

The Geneva Foundation

Investigators

View source on USAspending →